1. Home
  2. XNCR vs PRTH Comparison

XNCR vs PRTH Comparison

Compare XNCR & PRTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XNCR
  • PRTH
  • Stock Information
  • Founded
  • XNCR 1997
  • PRTH 2005
  • Country
  • XNCR United States
  • PRTH United States
  • Employees
  • XNCR N/A
  • PRTH N/A
  • Industry
  • XNCR Biotechnology: Pharmaceutical Preparations
  • PRTH EDP Services
  • Sector
  • XNCR Health Care
  • PRTH Technology
  • Exchange
  • XNCR Nasdaq
  • PRTH Nasdaq
  • Market Cap
  • XNCR 579.3M
  • PRTH 610.9M
  • IPO Year
  • XNCR 2013
  • PRTH N/A
  • Fundamental
  • Price
  • XNCR $9.65
  • PRTH $8.41
  • Analyst Decision
  • XNCR Buy
  • PRTH Strong Buy
  • Analyst Count
  • XNCR 8
  • PRTH 4
  • Target Price
  • XNCR $29.29
  • PRTH $12.25
  • AVG Volume (30 Days)
  • XNCR 968.8K
  • PRTH 393.2K
  • Earning Date
  • XNCR 08-04-2025
  • PRTH 05-06-2025
  • Dividend Yield
  • XNCR N/A
  • PRTH N/A
  • EPS Growth
  • XNCR N/A
  • PRTH N/A
  • EPS
  • XNCR N/A
  • PRTH N/A
  • Revenue
  • XNCR $127,228,000.00
  • PRTH $898,613,000.00
  • Revenue This Year
  • XNCR N/A
  • PRTH $12.70
  • Revenue Next Year
  • XNCR $29.35
  • PRTH $10.34
  • P/E Ratio
  • XNCR N/A
  • PRTH N/A
  • Revenue Growth
  • XNCR N/A
  • PRTH 15.76
  • 52 Week Low
  • XNCR $7.16
  • PRTH $3.92
  • 52 Week High
  • XNCR $27.24
  • PRTH $12.47
  • Technical
  • Relative Strength Index (RSI)
  • XNCR 59.62
  • PRTH 60.94
  • Support Level
  • XNCR $8.76
  • PRTH $8.18
  • Resistance Level
  • XNCR $9.60
  • PRTH $8.84
  • Average True Range (ATR)
  • XNCR 0.52
  • PRTH 0.43
  • MACD
  • XNCR 0.29
  • PRTH 0.07
  • Stochastic Oscillator
  • XNCR 90.87
  • PRTH 76.24

About XNCR Xencor Inc.

Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.

About PRTH Priority Technology Holdings Inc.

Priority Technology Holdings Inc is a provider of merchant acquiring and commercial payment solutions to small and medium business enterprises in the United States. The company has three reportable segments which are SMB Payments, B2B Payments, and Enterprise Payments. SMB Payments segment which generates the majority of revenue provides full-service acquiring and payment-enabled solutions for B2C transactions, leveraging Priority's proprietary software platform, distributed through ISO; the B2B Payments segment provides AP automation solutions to corporations, software partners, & industry FIs: and Enterprise Payments segment provides embedded payment & treasury solutions to enterprise customers to modernize legacy platforms & accelerate software partners' strategies to monetize payments.

Share on Social Networks: